|
End-of-day quote
Other stock markets
|
||
| - LVL | - |
|
| 22-01-07 | Delisting of AS "Olainfarm” shares from the Baltic Main list | AQ |
| 22-01-06 | Notification about results of final buy-back of shares | AQ |
| 21-12-30 | Notification about final share buy-back | AQ |
| 21-12-28 | Correction: Regarding results of a share buy-back offer | AQ |
| 21-12-28 | On substantial participation (4) - specified | AQ |
| Manager | Title | Age | Since |
|---|---|---|---|
Juris Hmelnickis
CEO | Chief Executive Officer | 46 | 2025-12-31 |
Janis Leimanis
DFI | Director of Finance/CFO | 56 | - |
| Chief Tech/Sci/R&D Officer | - | 2009-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 63 | 2021-06-18 | |
Janis Buks
CHM | Chairman | - | 2022-08-31 |
Roberts Tavjevs
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.68% | +2.13% | +16.17% | +77.49% | 48.36B | |
| +1.52% | +2.95% | +60.39% | +112.28% | 35.8B | |
| -0.09% | -0.66% | -8.03% | +31.90% | 11.83B | |
| -0.05% | -3.10% | +13.50% | +77.95% | 11.48B | |
| -0.37% | -0.37% | +37.53% | +142.08% | 9.01B | |
| +0.18% | +0.58% | +49.62% | -9.13% | 6.99B | |
| +0.95% | -2.00% | +12.78% | +32.58% | 6.7B | |
| +0.18% | -1.77% | +2.36% | +172.36% | 6.42B | |
| +3.51% | -10.57% | -31.55% | +0.09% | 5.3B | |
| Average | +0.83% | -1.21% | +16.97% | +70.85% | 15.77B | |
| Weighted average by Cap. | +1.11% | -0.14% | +25.53% | +81.62% |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- OLF1R Stock
- OLF1R Stock
Select your edition
All financial news and data tailored to specific country editions
